Hypera SA operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hypera SA with three other
pharmaceutical manufacturers in Latin America:
Instituto Hermes Pardini SA
(2020
sales of 1.49 billion Brazilian Reals [US$266.07 million]
of which 100%
was auxiliary diagnostic support services),
Fleury SA
(2.97 billion Brazilian Reals [US$529.22 million]
of which 82%
was Diagnostic Medicine), and
Diagnosticos Da America SA
(7.04 billion Brazilian Reals [US$1.25 billion]
of which 62%
was Outpatient).
Sales Analysis.
Hypera SA reported sales of 4.09 billion Brazilian Reals (US$728.19 million)
for the
year ending
December of 2020.
This
represents
an
increase of 24.1%
versus 2019, when the company's sales were 3.29 billion Brazilian Reals.